➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Colorcon
Medtronic
Mallinckrodt
McKesson

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208219


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 208219 describes LOTEMAX SM, which is a drug marketed by Bausch And Lomb Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the LOTEMAX SM profile page.

The generic ingredient in LOTEMAX SM is loteprednol etabonate. There are ten drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
Summary for 208219
Tradename:LOTEMAX SM
Applicant:Bausch And Lomb Inc
Ingredient:loteprednol etabonate
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 208219
Medical Subject Heading (MeSH) Categories for 208219
Suppliers and Packaging for NDA: 208219
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOTEMAX SM loteprednol etabonate GEL;OPHTHALMIC 208219 NDA Bausch & Lomb Incorporated 24208-507 24208-507-01 1 BOTTLE in 1 CARTON (24208-507-01) > .5 g in 1 BOTTLE
LOTEMAX SM loteprednol etabonate GEL;OPHTHALMIC 208219 NDA Bausch & Lomb Incorporated 24208-507 24208-507-02 1 BOTTLE in 1 CARTON (24208-507-02) > 5 g in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;OPHTHALMICStrength0.38%
Approval Date:Feb 22, 2019TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 22, 2022
Regulatory Exclusivity Use:NEW STRENGTH
Patent:  Start TrialPatent Expiration:Dec 23, 2036Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF POST-OPERATIVE INFLAMMATION AND PAIN FOLLOWING OCULAR SURGERY

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Mallinckrodt
McKesson
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.